Botulinum toxin type B: pH change reduces injection pain, retains efficacy

Dermatologic Surgery

Volumn 40, Issue 12, 2014, Pages 1328-1333

  Lowe, Philippa L ^a   Lowe, Nicholas J ^a,b  

^a Cranley Clinic   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BOTULINUM TOXIN B; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL EVALUATION; COMPUTER ANALYSIS; FACE MUSCLE; FEMALE; HUMAN; INJECTION PAIN; MALE; PAIN ASSESSMENT; PH; PILOT STUDY; CHEMISTRY; DRUG RESISTANCE; FACE; INJECTION; PAIN; PAIN MEASUREMENT; PHOTOGRAPHY; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXINS, TYPE A; DRUG RESISTANCE; FACE; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INJECTIONS; MALE; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PHOTOGRAPHY; TREATMENT OUTCOME;

EID: 84916641720     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1097/DSS.0000000000000178     Document Type: Article

References (17)

1. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 1973;12:924-7.
2. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-9.
3. Carruthers JD, Carruthers A. treatments of glabellar frown lines with botulinum - a exotoxin. J Dermatol Surg Oncol 1992;18:17-21.
4. Keen M, Blitzer A, Aviv J, Brin MF. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994;94:94-9.
5. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:569-72.
6. Carruthers JA, Lowe NJ, Menter MA, Gibson J, et al, BOTOX Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the ef ficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
7. Carruthers JD, Lowe NJ, Menter MA, Gibson J, et al, BOTOX Glabellar Lines II Study Group. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003;112:1089-98.
8. Lowe NJ, Ascher B, Heckmann M, Kumar C, et al, Botox Facial Aesthetics Study Team. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 2005;31:257-62.
9. Lowe NJ, Yamauchi PS, Lask GP, Moore D. Botulinum toxin types A and B for brow furrows: preliminary experiences with type B toxin dosing. J Cosmet Laser Ther 2002;4:15-8.
10. Kranz G, Sychia T, Voller B, Gleiss A, et al. Pain sensations during intradermal injection of three different botulinum toxin preparations in different doses and dilutions. Dermatol Surg 2006;32:886-90.
11. Blasi J, Chapman EJ, Link E, Binz T, et al Botulinum neurotoxin A selectively cleaves the synaptic SNAP-25. Nature 1993;365:160-3.
12. Goschel H, Wohlfarth K, Frevert J, Dengier R, et al. Botulinum toxin therapy. Neutralizing and non-neutralizing antibodies-therapeutic consequences. Exp Neurol 1997;147:96-102.
13. Schiavo G, Benfanti F, Poulain B, Rossetti O, et al. Tetanus and botulinum B neurotoxins block neuromuscular transmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359:832-5.
14. Lowe NJ, Shah A, Lowe PL, Patnaik R. Dosing, efficacy and safety plus computerized photography for botulinum toxins type A for upper facial lines. J Cosmet Laser Ther 2010;12:106-11.
15. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillary hyperhidrosis. J Neurol 2002;249:1729-32.
16. Rystedt A, Swartling A, Naver H. Anhydrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentration. Acta Dermatol Venereol 2008;88:229-33.
17. Lowe P, Patnaik R, Lowe NJ. Comparison of two formulations of botulinum type A for the treatment of glabellar lines: a double-blind randomized study. J Am Acad Dermatol 2006;55:975-80.